Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study Evaluating the Safety and Efficacy of Lower-Intensity INR Target (1.5-2.0) Versus Standard INR Target (2.0-3.0) in Patients Implanted With a HeartMate 3 Left Ventricular Assist Device (LVAD)

NCT07081035 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT07081035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07081035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study Evaluating the Safety and Efficacy of Lower-Intensity INR Target (1.5-2.0) Versus Standard INR Target (2.0-3.0) in Patients Implanted With a HeartMate 3 Left Ventricular Assist Device (LVAD)
Lead sponsor
Asan Medical Center
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 31, 2025
Completion date
January 31, 2029
Enrollment
94 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced heart failure, anticoagulation treatment, bleeding complications, left ventricular assist devices, thrombotic complications